GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Research & Development

4basebio (XTER:88Q) Research & Development : €3.08 Mil (TTM As of Jun. 2023)


View and export this data going back to 2021. Start your Free Trial

What is 4basebio Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. 4basebio's Research & Development for the six months ended in Jun. 2023 was €1.86 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 was €3.08 Mil.

4basebio Research & Development Historical Data

The historical data trend for 4basebio's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

4basebio Research & Development Chart

4basebio Annual Data
Trend Dec19 Dec20 Dec21 Dec22
Research & Development
0.28 0.36 1.91 2.39

4basebio Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23
Research & Development Get a 7-Day Free Trial 0.74 1.16 1.19 1.22 1.86

4basebio Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was €3.08 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

4basebio  (XTER:88Q) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

4basebio Research & Development Related Terms

Thank you for viewing the detailed overview of 4basebio's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

4basebio (XTER:88Q) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » 4basebio PLC (XTER:88Q) » Definitions » Research & Development
Comparable Companies
LSE:ETX LSE:AREC LSE:OBD LSE:DEST LSE:SBTX LSE:SAR LSE:FUM LSE:TRX LSE:REDX LSE:C4XD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
4BB:UK
Address
25 Norman Way, Over, Cambridge, GBR, CB24 5QE
Website
https://www.4basebio.com
4basebio PLC is a life sciences group focused on therapeutic DNA for gene therapies and DNA vaccines and providing solutions for the effective and safe delivery of these DNA-based products to patients. Its country of operation is the UK. It is engaged in the manufacturing and supply of high-purity, synthetic DNA for research, therapeutic and pharmacological use.

4basebio (XTER:88Q) Headlines

No Headlines